Table 1 Clinicopathological findings and correlation with PCDH1 expression.

From: PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1

Varialbes

No.(%)

PCDH7 low

PCDH7 high

P value

Total cases

197

100(50.8)

97(49.2)

 

Age(years)

 <60

100(50.8)

50(25.4)

50(25.4)

 

 ≥60

97(49.2)

47(25.9)

50(25.4)

0.828

Gender

 Female

88(44.7)

45(22.8)

43(21.8)

 

 Male

109(55.3)

52(26.4)

57(28.9)

0.632

Tumour location

 Head and neck

128(65.0)

60(30.5)

68(34.5)

 

 Body and tail

69(35.0)

37(18.8)

32(16.2)

0.366

Tumour invasive deptha

 T1–2

133(67.5)

58(29.4)

75(38.1)

 

 T3–4

64(32.5)

39(19.8)

25(12.7)

0.023b

Lymph node status

 <1

117(59.4)

66(33.5)

51(25.9)

 

 ≥1

80(40.6)

31(15.7)

49(24.9)

0.015b

Neural invasion

 Negative

112(57.9)

60(30.5)

52(26.4)

 

 Positive

85(42.1)

37(18.8)

48(24.4)

0.163

  1. aAccording to the 8th Edition of the AJCC Cancer Staging Manual.
  2. bStatistically significant, P < 0.05.